Case Report On Management and outcome of Cholangiocarcinoma

Abstract

Cholangiocarcinoma refers to cancer of the bile duct. The bile tubes, which move digesting fluid through the liver, are cancerous. It's Cancer that's uncommon yet fatal. Cholangiocarcinoma of the bile duct is rarer; this bile duct cancer is typically discovered in the presence of obstructive jaundice. Cholangiocarcinoma patients usually have locally advanced disease at the time of diagnosis, with distant metastasis being uncommon.
The following are the key symptoms and/or clinical findings: Abdominal pain, fever, yellow skin and eyes (jaundice), and loss of appetite were the primary complaints of a 52-year- an elderly woman of was hospitalized at A.V.B.R. Hospital. A physical examination, a blood test, and a Colour Doppler test were all performed. The most common diagnoses, therapeutic interventions, and outcomes are as follows: Following a physical examination, investigation, blood tests, and a color doppler test, the patient was diagnosed with cholangiocarcinoma. Following his diagnosis, the patient was treated by Inj. Monocot IV, 1gm, 12 hourly. Inj. Pantoprazole IV, 40 mg, every 12 hours; Emset, 4 mg, every 8 hours, Tab. Udil 300 mg orally twice a day, Tab. Ultracet 50 mg twice a day, Inj. Vitamin k gave, Inj. Tramadol in 100 ml NS SOS, Syp. Duphalac 10 ml H.S., inj.Piptaz In addition, a patient filling has improved. Also conducted was "Percutaneous Transhepatic Billary Drainage With Biliary Stenting." Cholangiocarcinoma, often known as bile duct cancer, is a rather uncommon condition. She responded well to all drugs and treatment, and she has made a wonderful recovery. Colangelo carcinoma is a phrase used to denote a form of cancer that affects the bile duct.